Cargando…
Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
Humoral deficiencies represent a broad group of disorders. The aim of the study was to compare the levels of antibodies against pneumococcal capsular polysaccharides (anti-PCP) and natural anti-galactosyl (anti-Gal) antibodies in (1) patients with chronic lymphocytic leukaemia (CLL), (2) patients wi...
Autores principales: | Kralickova, P., Kuhnova, J., Soucek, O., Vodarek, P., Zak, P., Simkovic, M., Motyckova, M., Smolej, L., Mala, E., Andrys, C., Krejsek, J., Thon, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748103/ https://www.ncbi.nlm.nih.gov/pubmed/29392143 http://dx.doi.org/10.1155/2017/7304658 |
Ejemplares similares
-
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia
por: Šimkovič, Martin, et al.
Publicado: (2015) -
A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia
por: Vodárek, Pavel, et al.
Publicado: (2022) -
Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
por: Smolej, Lukáš, et al.
Publicado: (2021) -
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
por: Pospiskova, Jana, et al.
Publicado: (2019) -
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
por: MacLeod, Colin M., et al.
Publicado: (1945)